Knockdown of Lumican Inhibits Proliferation and Migration of Bladder Cancer

Overview

Journal Transl Oncol

Specialty Oncology

Date 2019 Jun 10

PMID 31176992

Citations 14

Authors

Weipu Mao

Ming Luo

Xin Huang

Qian Wang

Jie Fan

Li Gao

Yanxiang Zhang

Jiang Geng

Affiliations

Soon will be listed here.

Abstract

Lumican (LUM) is differentially expressed between normal and cancer tissues. The purpose of this study was to investigate the role of LUM in the proliferation and migration of bladder cancer (BCa) cells. Our study included 97 cases of BCa diagnosis from our hospital between June 2013 and June 2016. The expression of LUM was analyzed by immunohistochemistry and Western blot. To characterize the function of LUM, BCa cells were stably infected with a lentivirus against LUM, and cell proliferation, migration and cell cycle were investigated. In addition, xenograft experiments were performed in nude mice to evaluate the role of LUM in BCa. Our results showed that LUM was overexpressed in BCa tissues and cell lines in comparison to normal tissues. LUM expression was related to pathological type, T stage and N stage (P < .05). In addition, depletion of LUM inhibited the proliferation and migration of BCa cells by inactivating MAPK signaling. In conclusion, LUM promotes the proliferation and migration of BCa cells and may serve as a potential therapeutic target for BCa.

Citing Articles

Repaglinide restrains HCC development and progression by targeting FOXO3/lumican/p53 axis.

Tan Y, Zhou Y, Zhang W, Wu Z, Xu Q, Wu Q Cell Oncol (Dordr). 2024; 47(4):1167-1181.

PMID: 38326640 DOI: 10.1007/s13402-024-00919-9.

The Landscape of Small Leucine-Rich Proteoglycan Impact on Cancer Pathogenesis with a Focus on Biglycan and Lumican.

Berdiaki A, Giatagana E, Tzanakakis G, Nikitovic D Cancers (Basel). 2023; 15(14).

PMID: 37509212 PMC: 10377491. DOI: 10.3390/cancers15143549.

Estimation of cell lineages in tumors from spatial transcriptomics data.

Ru B, Huang J, Zhang Y, Aldape K, Jiang P Nat Commun. 2023; 14(1):568.

PMID: 36732531 PMC: 9895078. DOI: 10.1038/s41467-023-36062-6.

The Anticancer Effect of a Novel Quinoline Derivative 91b1 through Downregulation of .

Zhou Y, Zhou Z, Chan D, Chung P, Wang Y, Chan A Int J Mol Sci. 2022; 23(21).

PMID: 36361971 PMC: 9655098. DOI: 10.3390/ijms232113181.

Extracellular matrix guidance of autophagy: a mechanism regulating cancer growth.

Chen C, Iozzo R Open Biol. 2022; 12(1):210304.

PMID: 34982945 PMC: 8727153. DOI: 10.1098/rsob.210304.

References

Iozzo R . The biology of the small leucine-rich proteoglycans. Functional network of interactive proteins. J Biol Chem. 1999; 274(27):18843-6. DOI: 10.1074/jbc.274.27.18843. View

Svensson L, Narlid I, Oldberg A . Fibromodulin and lumican bind to the same region on collagen type I fibrils. FEBS Lett. 2000; 470(2):178-82. DOI: 10.1016/s0014-5793(00)01314-4. View

Leygue E, Snell L, Dotzlaw H, Troup S, Murphy L, Roughley P . Lumican and decorin are differentially expressed in human breast carcinoma. J Pathol. 2000; 192(3):313-20. DOI: 10.1002/1096-9896(200011)192:3<313::AID-PATH694>3.0.CO;2-B. View

Saika S, Okada Y, Miyamoto T, Ohnishi Y, Ooshima A, McAvoy J . Smad translocation and growth suppression in lens epithelial cells by endogenous TGFbeta2 during wound repair. Exp Eye Res. 2001; 72(6):679-86. DOI: 10.1006/exer.2001.1002. View

Lu Y, Ishiwata T, Asano G . Lumican expression in alpha cells of islets in pancreas and pancreatic cancer cells. J Pathol. 2002; 196(3):324-30. DOI: 10.1002/path.1037. View

Lu Y, Ishiwata T, Kawahara K, Watanabe M, Naito Z, Moriyama Y . Expression of lumican in human colorectal cancer cells. Pathol Int. 2002; 52(8):519-26. DOI: 10.1046/j.1440-1827.2002.01384.x. View

Saika S, Miyamoto T, Ishida I, Shirai K, Ohnishi Y, Ooshima A . TGFbeta-Smad signalling in postoperative human lens epithelial cells. Br J Ophthalmol. 2002; 86(12):1428-33. PMC: 1771405. DOI: 10.1136/bjo.86.12.1428. View

Grzesiak J, Bouvet M . The alpha2beta1 integrin mediates the malignant phenotype on type I collagen in pancreatic cancer cell lines. Br J Cancer. 2006; 94(9):1311-9. PMC: 2361410. DOI: 10.1038/sj.bjc.6603088. View

Eshchenko T, Rykova V, Chernakov A, Sidorov S, Grigorieva E . Expression of different proteoglycans in human breast tumors. Biochemistry (Mosc). 2007; 72(9):1016-20. DOI: 10.1134/s0006297907090143. View

10.

Schaefer L, Iozzo R . Biological functions of the small leucine-rich proteoglycans: from genetics to signal transduction. J Biol Chem. 2008; 283(31):21305-9. PMC: 2490788. DOI: 10.1074/jbc.R800020200. View

11.

Radwanska A, Baczynska D, Nowak D, Brezillon S, Popow A, Maquart F . Lumican affects actin cytoskeletal organization in human melanoma A375 cells. Life Sci. 2008; 83(19-20):651-60. DOI: 10.1016/j.lfs.2008.09.008. View

12.

Matsuda Y, Yamamoto T, Kudo M, Kawahara K, Kawamoto M, Nakajima Y . Expression and roles of lumican in lung adenocarcinoma and squamous cell carcinoma. Int J Oncol. 2008; 33(6):1177-85. View

13.

Baghy K, Dezso K, Laszlo V, Fullar A, Peterfia B, Paku S . Ablation of the decorin gene enhances experimental hepatic fibrosis and impairs hepatic healing in mice. Lab Invest. 2010; 91(3):439-51. PMC: 5074558. DOI: 10.1038/labinvest.2010.172. View

14.

Salgado R, Favaro R, Zorn T . Modulation of small leucine-rich proteoglycans (SLRPs) expression in the mouse uterus by estradiol and progesterone. Reprod Biol Endocrinol. 2011; 9:22. PMC: 3041739. DOI: 10.1186/1477-7827-9-22. View

15.

de Wit M, Belt E, Delis-van Diemen P, Carvalho B, Coupe V, Stockmann H . Lumican and versican are associated with good outcome in stage II and III colon cancer. Ann Surg Oncol. 2012; 20 Suppl 3:S348-59. PMC: 3857876. DOI: 10.1245/s10434-012-2441-0. View

16.

Radwanska A, Litwin M, Nowak D, Baczynska D, Wegrowski Y, Maquart F . Overexpression of lumican affects the migration of human colon cancer cells through up-regulation of gelsolin and filamentous actin reorganization. Exp Cell Res. 2012; 318(18):2312-23. DOI: 10.1016/j.yexcr.2012.07.005. View

17.

Coulson-Thomas V, Coulson-Thomas Y, Gesteira T, De Paula C, Carneiro C, Ortiz V . Lumican expression, localization and antitumor activity in prostate cancer. Exp Cell Res. 2013; 319(7):967-81. PMC: 3633477. DOI: 10.1016/j.yexcr.2013.01.023. View

18.

Sharma B, Ramus M, Kirkwood C, Sperry E, Chu P, Kao W . Lumican exhibits anti-angiogenic activity in a context specific manner. Cancer Microenviron. 2013; 6(3):263-71. PMC: 3855379. DOI: 10.1007/s12307-013-0134-2. View

19.

Nikitovic D, Papoutsidakis A, Karamanos N, N Tzanakakis G . Lumican affects tumor cell functions, tumor-ECM interactions, angiogenesis and inflammatory response. Matrix Biol. 2013; 35:206-14. DOI: 10.1016/j.matbio.2013.09.003. View

20.

Geng J, Fan J, Ouyang Q, Zhang X, Zhang X, Yu J . Loss of PPM1A expression enhances invasion and the epithelial-to-mesenchymal transition in bladder cancer by activating the TGF-β/Smad signaling pathway. Oncotarget. 2014; 5(14):5700-11. PMC: 4170610. DOI: 10.18632/oncotarget.2144. View